List of partners

The following companies and organisations have confirmed their participation in the 35th ECNP Congress.
The content of the below mentioned websites, sessions or exhibition stands does not necessarily reflect the opinion of ECNP, nor does it engage its responsibility. 
The exhibition floor plan can be found here.

In alphabetical order: 

ALBA Network
Exhibition stand in Vienna, number 17
Online exhibition

The ALBA Network was created to promote equity and diversity in the brain sciences. The goals of ALBA are to recognize implicit bias and discrimination, and to provide better visibility and professional development opportunities to scientists from underrepresented groups in brain research. This is achieved by highlighting diverse scientist profiles through a series of interviews; organizing webinars discussing EDI issues, awards, mentoring sessions and networking events; and providing a platform to disseminate data and best practices towards creating a more inclusive brain research community. To discover all our activities and become a member, visit www.alba.network.

 

ALBA Network  

Angelini Pharma
Industry Satellite Symposium ISS.05 — Invitation flyer
Industry Product Theatre IPT.03 — Invitation flyer

Angelini Pharma is an international pharmaceutical company, part of the Italian privately-owned Angelini Industries. Angelini Pharma is committed to helping patients in the therapeutics areas of Brain Health, Rare Diseases and Consumer Healthcare.
Angelini Pharma operates directly in 25 countries employing almost 3.000 people and commercializes its products in more than 50 countries through strategic alliances with leading international pharmaceutical groups.
www.angelinipharma.com

 

Angelini Pharma 

Biogen
Industry Satellite Symposium ISS.10 — Invitation flyer
Exhibition stand in Vienna, number 3

Biogen is a global biopharmaceutical company focused on discovering, developing and delivering worldwide innovative therapies for people living with serious neurological and neurodegenerative diseases as well as related therapeutic adjacencies. Our core growth areas include multiple sclerosis and neuroimmunology; Alzheimer’s disease and dementia; neuromuscular disorders, including spinal muscular atrophy; movement disorders; and neuropsychiatry. We are also focused on discovering, developing and delivering worldwide innovative therapies in our emerging growth areas of immunology and acute neurology. In addition, we commercialize biosimilars of advanced biologics.
www.biogen.com

 

Biogen 

Boehringer Ingelheim
Industry Satellite Symposium ISS.01 — Invitation flyer
Industry Satellite Symposium ISS.08 — Invitation flyer
Industry Interactive Discussion IID.01 — Invitation flyer 
Exhibition stand in Vienna, number 1
Online exhibition

At Boehringer Ingelheim Mental Health, we are redefining mental health to enable people to thrive. We link behavior to the underlying neurobiology to develop targeted therapies that can ease the burden of these conditions, not just the symptoms. By combining traditional treatment approaches with new and innovative approaches and technologies, we will enable those with mental health conditions to create more meaningful connections to their lives, loved ones and society.
www.boehringer-ingelheim.com
http://annualreport.boehringer-ingelheim.com

 

 Boehringer Ingelheim

Campden Instruments
Exhibition stand in Vienna, number 11

The Bussey-Saksida rodent touch screen system and MCANTAB for primates is your proven Translational Task Battery for clinically relevant neurology.
Established in over 300 labs and pharma-academic partnerships worldwide over the past decade, containing an expanding battery of Tasks with relevance for all the prevalent neurological conditions.
Highly standardised, this ‘plug & play’ system, complete with all training stages for each paradigm, becomes productive very quickly, after installation in the laboratory.
Data has been shown to be highly reproducible across many labs worldwide.
MCANTAB publications have a 20-year history originating from the University of Cambridge.
www.campdeninstruments.com

 

Campden Instruments 

Douglas Pharmaceuticals Ltd
Industry Interactive Discussion IID.03 — Invitation flyer

Douglas Pharmaceuticals is the largest New Zealand owned pharmaceutical company, founded in 1967 and today has more than 700 employees. At Douglas, we are focused on making a positive difference in healthcare outcomes for people around the globe. We work with innovative partners to research and develop, manufacture, market and distribute prescription, nutraceutical, and consumer healthcare products. Our therapeutic focus includes CNS, oncology, and dermatology. The Douglas vision is to improve people's lives.
https://www.douglas.co.nz/

 

Douglas improving lives 

EUFAMI
Exhibition stand in Vienna, number 14
Online exhibition

EUFAMI is the European organisation supporting national family organsations of persons with Mental Illness. We advocate on behalf of families and carers for greater involvement of family carers in the delivery of good mental health care services.
www.eufami.org

 

 EUFAMI

European Brain Council (EBC)
Exhibition stand in Vienna, number 16
Online exhibition

The European Brain Council (EBC) is a network of key players in the “Brain Area”, with a membership encompassing scientific societies, patient organisations, professional societies and industry partners. A non-profit organisation based in Brussels, its main mission is to promote brain research with the ultimate goal of improving the lives of the estimated 179 million Europeans living with brain conditions. With the aim to speak with one voice, EBC stands as the platform to foster cooperation between its member organisations and other stakeholders, consistently promoting dialogue between scientists, industry and society.
www.braincouncil.eu

 

European Brain Council 

European Psychiatric Association (EPA)
Online Exhibition

The EPA aims to improve Psychiatry and Mental Health Care in Europe. With active individual members in as many as 88 countries and 44 National Psychiatric Association Members who represent more than 80,000 European psychiatrists, the European Psychiatric Association is the main association representing psychiatry in Europe. The EPA’s activities address the interests of psychiatrists in academia, research and practice throughout all stages of career development. The EPA deals with psychiatry and its related disciplines and focuses on the improvement of care for the mentally ill as well as on the development of professional excellence.
www.europsy.net

 

European Psychiatric Association (EPA) 

GAMIAN-Europe
Exhibition Stand in Vienna, number 13
Online exhibition

GAMIAN-Europe, is a non-profit patient-driven pan-European organisation, representing and advocating for the interests and rights of persons affected by mental ill-health. Our main activities include awareness-raising, education, partnership and capacity building. Overarching themes in our work relate to anti-stigma, discrimination and patients’ rights.
www.gamian.eu

 

 GAMIAN-EUROPE

Gedeon Richter Plc & RECORDATI S.p.A
Industry Satellite Symposium ISS.09 — Invitation flyer
Industry Product Theatre IPT.06 — Invitation flyer
Exhibition stand in Vienna, number 2

Headquartered in Hungary, Gedeon Richter is an innovation-driven speciality pharmaceutical company, boasting the biggest pharmaceutical research centre in CEU. One of its latest achievements is the original antipsychotic compound, cariprazine, already marketed in the US for BD and schizophrenia treatment and in the majority of the EU countries for the treatment of schizophrenia in adult patients.
www.gedeonrichter.com/

Richter Gedeon

Recordati is an international pharmaceutical group, listed on the Italian Stock Exchange, dedicated to the research, development and marketing of pharmaceuticals products. Recordati is committed to the research and development of new specialities in cardiovascular, urological and psychiatric areas with a focus on treatments for rare diseases.
www.recordati.it

 

Recordati 

H. Lundbeck A/S
Industry Satellite Symposium ISS.07 — Invitation flyer
Industry Mini Session IMS.01 — Invitation flyer
Exhibition stand in Vienna, number 5


Lundbeck is a global pharmaceutical company specialized in discovering and developing innovative treatments for brain diseases. At Lundbeck, we are tirelessly dedicated to restoring brain health, so every person can be their best.
www.lundbeck.com

 

Lundbeck 

Janssen Pharmaceutica NV
Industry Satellite Symposium ISS.04 — Invitation flyer
Industry Satellite Symposium ISS.11 — Invitation flyer
Industry Interactive Discussion IID.02 — Invitation flyer
Industry Product Theatre IPT.04 — Invitation flyer
Exhibition stand in Vienna, number 7
Online exhibition

At Janssen, we’re creating a future where disease is a thing of the past. We’re the Pharmaceutical Companies of Johnson & Johnson, working tirelessly to make that future a reality for patients everywhere by fighting sickness with science, improving access with ingenuity, and healing hopelessness with heart. We focus on areas of medicine where we can make the biggest difference: Cardiovascular & Metabolism, Immunology, Infectious Diseases & Vaccines, Neuroscience, Oncology, and Pulmonary Hypertension.
Janssen Pharmaceutica NV is one of the Janssen Pharmaceutical Companies of Johnson & Johnson.
www.twitter.com/JanssenEMEA
www.janssen.com/emea

 

Janssen 

MSD
Exhibition stand in Vienna, number 8

At MSD, known as Merck & Co., Inc., Rahway, NJ, USA in the United States and Canada, we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world. For more than a century, we’ve been at the forefront of research, bringing forward medicines, vaccines and innovative health solutions for the world’s most challenging diseases.
www.msd.com

 

MSD 

Neuroscience-based Nomenclature (NbN)
Exhibition stand in Vienna, number 12
Online exhibition

The need to update the current, 60-years-old disease-based nomenclature is clear. NbN provides an updated, pharmacologically driven, neuroscience-based nomenclature for psychotropics. It aims to help the clinician in rational prescribing, to decrease confusion for the patient (no more “antipsychotics” for depression or “antidepressants” for anxiety phenomena), to harmonize psychiatry with other fields in medicine, and to enrich the psychiatric toolbox by using pharmacological domains and mode of action to describe the 60 different types of pharmacological tools that are currently available for use.
www.nbn2r.com

 

Neuroscience based Nomenclature (NbN) 

Otsuka Pharmaceutical Europe Ltd and H. Lundbeck A/S
Industry Satellite Symposium ISS.03 — Invitation flyer
Industry Product Theatre IPT.02 — Invitation flyer
Exhibition stand in Vienna, number 6

 

Otsuka   Lundbeck

Otsuka Pharmaceutical Development & Commercialization Inc. and H. Lundbeck A/S
Industry Satellite Symposium ISS.13Invitation flyer
This independent medical educational Industry Satellite Symposium is organised by Medscape Education

Otsuka Pharmaceutical is a global healthcare company with the corporate philosophy: 'Otsuka-people creating new products for better health worldwide.'
Otsuka’s 47,000 employees ensure that patients have access to innovative products and medical devices in our key therapy areas of mental health, oncology, cardio-renal and nephrology.
Lundbeck is a global pharmaceutical company specialized in discovering and developing innovative treatments for brain diseases. At Lundbeck, we are tirelessly dedicated to restoring brain health, so every person can be their best.
www.otsuka-us.com; www.lundbeck.com

 

Medscape educational global
 
 
 

Sahlgrenska University Hospital
Exhibition stand in Vienna, number 15

Sahlgrenska University Hospital (Gothenburg, SWEDEN) is one of northern Europes' largest hospital with the mission to perform and develop top class health care services, research and innovation. Our psychiatry care is organized in five subspecialized clinics; Affective Disorders, Addictions, Psychosis, Geriatrics and Forensic psychiatry, all of which put emphasis on their professors and research teams connected to each clinic in order to build the future, human and digital, psychiatry care. Together for the patient, with the patient is our hospital motto.
www.sahlgrenska.se

 

Sahlgrenska University Hospital 

Sage Therapeutics
Industry Satellite Symposium ISS.10 — Invitation flyer

Sage Therapeutics is a biopharmaceutical company fearlessly leading the way to create a world with better brain health. Our mission is to pioneer solutions to deliver life-changing brain health medicines, so every person can thrive.
www.sagerx.com

 

Sage Therapeutics and Biogen 

Schwabe Group
Industry Mini Session IMS.03 — Invitation flyer
Exhibition stand in Vienna, number 10


Schwabe's main indication areas include cognitive decline with neuropsychiatric symptoms, anxiety disorders, and depression. The efficacy and safety of our plant-based medication has been demonstrated in dozens of randomized, placebo-controlled clinical trials, that were designed according to the highest clinical trial standards. Schwabe medication has been recommended in national and international medical guidelines. The company has been family-owned since the great-grandfather of the current CEO Olaf Schwabe founded it in 1865. In its 157-year history, it has remained committed to its tradition of being the driver of consistent innovation in safe and evidence-based treatments that your patients appreciate.
www.schwabe-group.com/en/

 

 Schwabe Group

Sumitomo Pharma Co., Ltd.
Industry Satellite Symposium ISS.05 — Invitation flyer

Corporate Mission of Sumitomo Pharma is to broadly contribute to society through value creation based on innovative research and development activities for the betterment of healthcare and fuller lives of people worldwide, with the global slogan of "Innovation today, healthier tomorrows". The global slogan reflects our full commitment to deliver to society revolutionary pharmaceuticals, acquired through groundbreaking ideas and high-standard research and development by each individual employee's challenge for innovation, so as to help enable the patients and their families lead healthier and fulfilling lives. Our research area focuses on Psychiatry & Neurology, Oncology and Regenerative medicine/Cell therapy.
www.sumitomo-pharma.com 

 

Sumitomo Pharma 

Sunovion Pharmaceuticals Europe Ltd
Industry Satellite Symposium ISS.05 — Invitation flyer
Industry Satellite Symposium ISS.12 — Invitation flyer

At Sunovion, we are focused on the innovative application of science and medicine to improve the quality of life for those living with serious central nervous system (CNS) conditions. This momentum continues, fueled by the conviction that science excellence paired with meaningful advocacy, community support, collaborative approaches and a diverse workforce can unlock advances and bring forward important new medicines to improve lives. Every day, Sunovion is committed to delivering the next generation of neuropsychiatric treatments to lead the way to a healthier world.
www.sunovion.com

 

Sunovion 

Takeda Pharmaceuticals
Industry Mini Session IMS.02 — Invitation flyer
Industry Product Theatre IPT.05Invitation flyer

Takeda is a global, values-based, R&D-driven biopharmaceutical leader headquartered in Japan, committed to bringing Better Health and a Brighter Future to patients by translating science into highly-innovative medicines. Takeda focuses its R&D efforts on four therapeutic areas: Neuroscience, Oncology, Rare Diseases and Gastroenterology. We also make targeted R&D investments in Plasma-Derived Therapies and Vaccines. We are focusing on developing highly innovative medicines that contribute to making a difference in people's lives by advancing the frontier of new treatment options and leveraging our enhanced collaborative R&D engine and capabilities to create a robust, modality-diverse pipeline.
www.takeda.com

 

Shire Denmark - Takeda group 

Viatris
Industry Satellite Symposium ISS.06 — Invitation flyer
Exhibition stand in Vienna, number 4
Online exhibition

Viatris is a global healthcare company formed in 2020 through the combination of Mylan and Upjohn, a legacy division of Pfizer. By integrating the strengths of these two companies, we aim to deliver increased access to affordable, quality medicines for patients worldwide, regardless of geography or circumstance.
Our global portfolio includes best-in-class, iconic brand-name products as well as global key brands; generics, including branded and complex generics; biosimilars; and over-the-counter offerings across a wide range of therapeutic areas. We are committed to helping create healthier communities worldwide through education, outreach and better access to treatment.
www.viatris.com

Viatris 
Wisepress Medical Bookshop
Exhibition stand in Vienna, number 18

Wisepress.com, Europe’s leading conference bookseller, attend around 200 conferences every year. We have an extensive range of books and journals relevant to the themes of this conference available at our booth. We also have a comprehensive range of STM titles available on our online bookshop. Follow us on Twitter @WisepressBooks.
www.wisepress.com